{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-010965","form_type":"8-K/A","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.628713+00:00","generated_at":"2026-05-16T04:17:51.432788+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Standard BioTools completes sale of SomaScan business to Illumina for ~$363.7M net cash","bullets":["Net cash proceeds of ~$363.7M from sale of SomaLogic and Sengenics entities to Illumina.","Potential earnout payments up to $75M based on 2025/2026 revenue milestones.","Pro forma cash and equivalents of $478.3M as of Sep 30, 2025; gain on sale of $161.9M.","Company retains mass cytometry and microfluidics businesses; no longer party to Collaboration Agreement.","Transaction expenses of $18.4M incurred; $14.8M paid at closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-010965","json":"https://secwatch.observer/filing/0001104659-26-010965.json","markdown":"https://secwatch.observer/filing/0001104659-26-010965.md","text":"https://secwatch.observer/filing/0001104659-26-010965.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000110465926010965/0001104659-26-010965-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000110465926010965/tm265294d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:17:51.432788+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}